In addition to its role in the development of tumor resistance, MITF acts as a master regulator of melanocyte differentiation through the upregulation of receptor tyrosine kinases (RTKs) including the AXL, EGFR, and PDGFRβ [53,54]. Here, MITF is linked to neoplasm.